Vertex Pharmaceuticals Incorporated (BMV:VRTX)

Vertex Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,972	4,570	10,369	10,504	6,795	5,988
Short-Term Investments	1,411	1,546	849.2	274.5	729.9	670.7
Cash & Short-Term Investments	6,383	6,116	11,218	10,779	7,525	6,659
Cash Growth	10.13%	-45.48%	4.08%	43.24%	13.00%	74.85%
Accounts Receivable	1,894	1,609	1,563	1,442	1,137	885.4
Inventory	1,499	1,205	738.8	460.6	353.1	280.8
Other Current Assets	652.3	665.7	623.7	553.5	545.8	308.3
Total Current Assets	10,428	9,596	14,144	13,235	9,561	8,133
Net Property, Plant & Equipment	2,649	2,585	1,453	1,456	1,424	1,284
Other Intangible Assets	435.5	825.9	839.9	603.6	400	400
Goodwill	1,088	1,088	1,088	1,088	1,002	1,002
Long-Term Investments	5,646	5,108	2,498	112.2	-	-
Other Long-Term Assets	3,791	3,330	2,707	1,657	1,045	932.1
Total Assets	24,037	22,533	22,730	18,151	13,433	11,752
Accounts Payable	442.3	413	364.9	303.9	195	155.1
Accrued Expenses	3,271	2,789	2,655	2,127	1,679	1,405
Other Current Liabilities	425.4	363	527.2	311.5	268.4	317.4
Total Current Liabilities	4,138	3,565	3,547	2,742	2,142	1,878
Long-Term Leases	1,527	1,544	724.7	810.3	887.2	889.5
Other Long-Term Liabilities	1,196	1,015	877.7	685.8	303.3	298
Total Long-Term Liabilities	2,723	2,559	1,602	1,496	1,191	1,188
Total Liabilities	6,861	6,124	5,150	4,238	3,333	3,065
Preferred Stock	-	-	2.6	2.6	-	-
Common Stock	2.6	2.6	2.6	-	2.5	2.6
Additional Paid-in Capital	5,988	6,672	7,450	7,387	6,881	7,894
Accumulated Other Comprehensive Income	-101.1	127.8	-14.3	0.8	15.9	-68.5
Retained Earnings	11,286	9,607	10,142	6,523	3,201	858.7
Total Common Shareholders' Equity	17,175	16,410	17,583	13,913	10,100	8,687
Shareholders' Equity	17,175	16,410	17,580	13,913	10,100	8,687
Total Liabilities & Equity	24,037	22,533	22,730	18,151	13,433	11,752
Total Debt	1,527	1,544	724.7	810.3	887.2	889.5
Net Cash (Debt)	4,855	4,572	10,494	9,968	6,638	5,769
Net Cash Growth	6.21%	-56.44%	5.27%	50.18%	15.05%	81.12%
Net Cash Per Share	18.73	17.73	40.28	38.47	25.54	21.90
Book Value	17,175	16,410	17,583	13,913	10,100	8,687
Book Value Per Share	66.27	63.63	67.50	53.70	38.86	32.98
Tangible Book Value	15,652	14,496	15,655	12,221	8,698	7,285
Tangible Book Value Per Share	60.39	56.21	60.10	47.17	33.47	27.66

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.